Moffitt identifies genomic and immune indicators that predict lethal outcomes in prostate cancer ...Middle East

Moffitt Cancer Center researchers conducted studies to determine if genomic heterogeneity in tumors from grade 4/5 prostate cancer patients can be exploited to identify patient subsets that are at higher risk for lethal outcomes and that may benefit from targeted treatment strategies. Their results were published in the journal European Urology.

Hence then, the article about moffitt identifies genomic and immune indicators that predict lethal outcomes in prostate cancer was published today ( Tuesday 15/12/2020 - 07:45 PM ) and is available on ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Moffitt identifies genomic and immune indicators that predict lethal outcomes in prostate cancer )

Also on site :

• Tehran, Washington freeze strikes ahead of talks
• Mozilla President: meet the open source ‘rebel alliance’ that could break Big Tech’s grip on AI
• Ayatollah Khamenei funeral: Bihar guv, external affairs MoS to attend - report